NUVO.Q Stock Overview
Engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Holdco Nuvo Group D.G Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0044 |
| 52 Week High | US$21.50 |
| 52 Week Low | US$0.004 |
| Beta | 0 |
| 11 Month Change | -97.41% |
| 3 Month Change | -99.58% |
| 1 Year Change | -99.96% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| NUVO.Q | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -12.0% | -0.6% | 0.9% |
| 1Y | -100.0% | 20.8% | 32.3% |
Return vs Industry: NUVO.Q underperformed the US Medical Equipment industry which returned 20.8% over the past year.
Return vs Market: NUVO.Q underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| NUVO.Q volatility | |
|---|---|
| NUVO.Q Average Weekly Movement | 45.0% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: NUVO.Q's share price has been volatile over the past 3 months.
Volatility Over Time: NUVO.Q's weekly volatility has increased from 39% to 45% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Rice Powell | www.nuvocares.com |
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company’s INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools.
Holdco Nuvo Group D.G Ltd Fundamentals Summary
| NUVO.Q fundamental statistics | |
|---|---|
| Market cap | US$159.53k |
| Earnings (TTM) | -US$37.76m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs NUVO.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUVO.Q income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$37.76m |
| Earnings | -US$37.76m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NUVO.Q perform over the long term?
See historical performance and comparison